The analysis also shows real-world evidence of the vaccine's effectiveness against a highly infectious variant of COVID-19 first discovered in Britain.

Cole Pinnow said the National Advisory Committee on Immunization did not contact Pfizer before it recommended changes to the dosing schedule.